Insider · CIK 0001870486
DAmour Kevin
Reports to the SEC for 1 company · BROOKLYN, NY
Transactions
7
Companies
1
Filings
4
CIK
0001870486
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-06-28 | ERNAErnexa Therapeutics Inc.M Exercise/Conversion | — |
| 2022-06-28 | ERNAErnexa Therapeutics Inc.F Tax Payment | −$3,363.012 |
| 2022-06-28 | ERNAErnexa Therapeutics Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2022-03-11 | ERNAErnexa Therapeutics Inc. · Stock Option (Right to buy)A Award | — |
| 2022-03-11 | ERNAErnexa Therapeutics Inc. · Stock Option (Right to buy)A Award | — |
| 2021-06-28 | ERNAErnexa Therapeutics Inc. · Stock OptionA Award | — |
| 2021-06-28 | ERNAErnexa Therapeutics Inc. · Restricted Stock UnitA Award | — |
Recent filings
- 4DAmour Kevin0001140361-22-024524SEC(opens sec.gov)
- 4/ADAmour Kevin0001140361-22-009984SEC(opens sec.gov)
- 4DAmour Kevin0001140361-22-009664SEC(opens sec.gov)
- 4DAmour Kevin0001140361-21-023007SEC(opens sec.gov)
Companies
Address
C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100
BROOKLYN, NY, 11220